Cronos (CRON) Notes Payables (2019 - 2025)

Cronos' (CRON) quarterly Notes Payables came in at $3000.0 in Q2 2025, down 85.71% year-on-year from $21000.0 in Q2 2024, and down 76.92% quarter-over-quarter from $13000.0 in Q1 2025.

Cronos (CRON) Notes Payables (2019 - 2025) Analysis & Trends

Cronos' Notes Payables history runs 7 years deep, the most recent figure standing at $3000.0 for Q2 2025.

  • On a quarterly basis, Notes Payables fell 85.71% year-over-year to $3000.0 in Q2 2025; TTM through Jun 2025 was $3000.0, a 85.71% decrease from a year earlier, with the FY2024 full-year figure at $40000.0, down 60.78% from the prior year.
  • Notes Payables retreated to $3000.0 in Q2 2025 per CRON's latest filing, from $13000.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $272.3 million in Q1 2021 and bottomed at $3000.0 in Q2 2025.
  • The 5-year median for Notes Payables is $91000.0 (2023), against an average of $27.6 million.
  • Across the five-year window, Notes Payables sank 99.9% in 2022 and surged 580.0% in 2023, its largest moves.
  • Year by year, Notes Payables stood at $14.4 million in 2021, then sank by 99.9% to $15000.0 in 2022, then jumped by 580.0% to $102000.0 in 2023, then sank by 60.78% to $40000.0 in 2024, then tumbled by 92.5% to $3000.0 in 2025.
  • Per Business Quant, the three latest CRON Notes Payables figures stand at $3000.0 (Q2 2025), $13000.0 (Q1 2025), and $40000.0 (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Cronos 1.04 Bn 267.78 Mn 19.15 Mn

Historic Data

Download Data
DateValue
Jun 30, 2025 3,000.00
Mar 31, 2025 13,000.00
Dec 31, 2024 40,000.00
Sep 30, 2024 192,000.00
Jun 30, 2024 21,000.00
Mar 31, 2024 118,000.00
Dec 31, 2023 102,000.00
Sep 30, 2023 29,000.00
Jun 30, 2023 37,000.00
Mar 31, 2023 80,000.00
Dec 31, 2022 15,000.00
Sep 30, 2022 73,000.00
Jun 30, 2022 574,000.00
Mar 31, 2022 4.10 Mn
Dec 31, 2021 14.38 Mn
Sep 30, 2021 34.53 Mn
Jun 30, 2021 169.56 Mn
Mar 31, 2021 272.30 Mn
Dec 31, 2020 163.41 Mn
Sep 30, 2020 102.66 Mn